Valuation: Psychemedics Corporation

Market Cap 9.79M 8.73M 8.08M 7.35M 13.79M 928M 14.02M 96.97M 38.13M 485M 36.74M 35.97M 1.55B P/E 2023
-4.09x
P/E 2024 -7x
Enterprise Value 9.54M 8.5M 7.88M 7.16M 13.44M 904M 13.66M 94.49M 37.16M 473M 35.79M 35.04M 1.51B EV / Sales 2023
0.79x
EV / Sales 2024 0.68x
Free-Float
44.15%
Yield 2023
2.36%
Yield 2024 -
1 week-3.61%
Current month-3.61%
1 month-3.61%
3 months-3.61%
6 months+0.42%
Current year+50.00%
Current year 1.33
Extreme 1.33
2.7
1 year 1.33
Extreme 1.33
2.7
3 years 1.11
Extreme 1.11
3.93
5 years 1.11
Extreme 1.11
8.9
10 years 1.11
Extreme 1.11
27.99
Manager TitleAgeSince
Chief Executive Officer 59 17/08/2023
Director of Finance/CFO 36 27/11/2023
Corporate Officer/Principal 40 21/09/2023
Director TitleAgeSince
Director/Board Member 64 16/03/2021
Director/Board Member 58 04/04/2022
Director/Board Member 64 12/08/2022
Date Insider Type Main position Quantity % Market Cap. Importance
13/12/24
Powell Anderson Capital Partners
BuyCompany 159,700 2.7093%
10/12/24
Powell Anderson Capital Partners
BuyCompany 86,991 1.4758%
10/12/24 Sell

Director

320,708 5.4408%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-3.61%+14.29%-14.90% 15.26M
+0.35%+7.57%+12.31%+30.37% 118B
-0.86%+0.84%+6.74%+87.57% 99.34B
+1.52%-0.32%+119.84%+853.72% 56.71B
-0.59%+6.42%-5.38%+81.83% 28.56B
-0.04%+1.71%+23.96%+91.31% 25.94B
+0.28%+2.14%+11.50%+58.03% 25.79B
-0.32%+0.99%+33.20%+378.00% 21.52B
-1.26%-3.69%-20.98%-3.86% 20.7B
+1.83%-2.65%+5.55%+87.66% 18.25B
Average +0.09%+0.74%+20.10%+164.97% 41.5B
Weighted average by Cap. -0.05%+2.41%+24.26%+184.50%

Financials

2023 2024
Net sales 22.1M 19.7M 18.25M 16.59M 31.13M 2.1B 31.64M 219M 86.06M 1.1B 82.91M 81.17M 3.5B 19.68M 17.55M 16.25M 14.78M 27.73M 1.87B 28.19M 195M 76.67M 975M 73.86M 72.31M 3.12B
Net income -4.15M -3.7M -3.43M -3.12M -5.85M -394M -5.95M -41.14M -16.18M -206M -15.59M -15.26M -658M -1.86M -1.66M -1.54M -1.4M -2.62M -176M -2.66M -18.43M -7.25M -92.22M -6.98M -6.84M -295M
Net Debt 334K 298K 276K 251K 471K 31.67M 478K 3.31M 1.3M 16.55M 1.25M 1.23M 52.91M -251K -224K -207K -188K -354K -23.8M -359K -2.49M -978K -12.44M -942K -922K -39.76M
Projected Income Statement - Annual - Psychemedics Corporation
Logo Psychemedics Corporation
Psychemedics Corporation is a hair drug testing company. The Company provides testing services for the detection of drugs of abuse through the analysis of hair samples. Its testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The Company customizes its enzyme immunoassay (EIA) procedures to drug test hair samples. It provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines (including ecstasy, eve, and Adderall), opiates (including heroin, hydrocodone, hydromorphone, oxycodone and codeine), synthetic cannabinoids (including K2, Spice, Blaze), benzodiazepines (Xanax, Valium, and Ativan), nicotine, Fentanyl, and alcohol. The Company markets its corporate drug testing services through its own sales force, distributors, and partners. It markets its home drug testing service, PDT-90, through the Internet.
Employees
101
  1. Stock Market
  2. Stocks
  3. PMDI Stock